Home » Topics » BioWorld Science

BioWorld Science
RSS

New phase I trial investigates MB-108 in recurrent glioblastoma multiforme

Oct. 25, 2019

Syros reports new data from phase II trial of SY-1425 in newly diagnosed unfit AML

Oct. 25, 2019

Japan Tobacco describes new SLC5A1 inhibitors

Oct. 25, 2019

Merck KGaA synthesizes new IRAK inhibitors

Oct. 25, 2019

AbbVie and Galapagos identify mutant CFTR correctors for cystic fibrosis

Oct. 25, 2019

Janssen Pharmaceutica presents new ionotropic glutamate GluN2B receptor antagonists

Oct. 25, 2019

Aurigene Discovery Technologies divulges CDK12 and CDK13 inhibitors

Oct. 25, 2019

New glutamate receptor modulator DT-095435 shows impressive in vivo antiparkinsonian potential

Oct. 25, 2019

SUVN-1702012 for psychiatric disorders balancing antipsychotic and motor side effects

Oct. 25, 2019

Serum chemerin shows potential as marker to diagnose and grade NAFLD

Oct. 25, 2019

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 26, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 23, 2026
Brain-computer interfaces are here but long road ahead
BioWorld
The field of BCI is continually evolving; as such, companies are increasingly highlighting the potential of their technologies to transform care. For advanced...
Case report links APOLD1 variant to vascular-type bleeding disorder
BioWorld Science
Vascular-type bleeding disorder (BDVAS) is a rare, autosomal dominant disorder mainly caused by impaired vascular integrity.
2026 marks critical turning point for BCI technology
BioWorld
Decades of research are helping unravel the “black box” of the brain. The second article in BioWorld’s series on the Brain-Computer Interface (BCI) field looks at...